Elutia Inc. (ELUT)
NASDAQ: ELUT · Real-Time Price · USD
0.8907
-0.0094 (-1.04%)
At close: Oct 17, 2025, 4:00 PM EDT
0.9000
+0.0093 (1.04%)
After-hours: Oct 17, 2025, 7:07 PM EDT
Elutia Market Cap
Elutia has a market cap or net worth of $37.76 million as of October 17, 2025. Its market cap has decreased by -70.90% in one year.
Market Cap
37.76M
Enterprise Value
57.50M
1-Year Change
-70.90%
Ranking
Category
Stock Price
$0.89
Market Cap Chart
Since the IPO on October 8, 2020, Elutia's market cap has decreased from $173.84M to $37.76M, a decrease of -78.28%. That is a compound annual growth rate of -26.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 37.76M | -70.79% |
| Dec 31, 2024 | 129.26M | 157.97% |
| Dec 29, 2023 | 50.11M | -26.88% |
| Dec 30, 2022 | 68.53M | -19.77% |
| Dec 31, 2021 | 85.42M | -38.72% |
| Dec 31, 2020 | 139.38M | -19.82% |
| Oct 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 742.04B |
| Johnson & Johnson | 460.40B |
| AbbVie | 399.63B |
| UnitedHealth Group | 327.08B |
| AstraZeneca | 262.65B |
| Novartis AG | 252.43B |
| Novo Nordisk | 251.88B |
| Abbott Laboratories | 225.30B |